FR2932682B1 - Nouvelles formes pharmaceutiques a effet rapide et les utilisations des compositions pharmaceutiques ainsi obtenus. - Google Patents

Nouvelles formes pharmaceutiques a effet rapide et les utilisations des compositions pharmaceutiques ainsi obtenus.

Info

Publication number
FR2932682B1
FR2932682B1 FR0803499A FR0803499A FR2932682B1 FR 2932682 B1 FR2932682 B1 FR 2932682B1 FR 0803499 A FR0803499 A FR 0803499A FR 0803499 A FR0803499 A FR 0803499A FR 2932682 B1 FR2932682 B1 FR 2932682B1
Authority
FR
France
Prior art keywords
rapid effect
pharmaceutical compositions
novel
forms
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0803499A
Other languages
English (en)
Other versions
FR2932682A1 (fr
Inventor
Patrice Binay
Francois Andre Allaert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIONETWORK
Original Assignee
BIONETWORK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIONETWORK filed Critical BIONETWORK
Priority to FR0803499A priority Critical patent/FR2932682B1/fr
Priority to EP09784216A priority patent/EP2323627A1/fr
Priority to PCT/FR2009/000752 priority patent/WO2010007232A1/fr
Publication of FR2932682A1 publication Critical patent/FR2932682A1/fr
Application granted granted Critical
Publication of FR2932682B1 publication Critical patent/FR2932682B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0803499A 2008-06-23 2008-06-23 Nouvelles formes pharmaceutiques a effet rapide et les utilisations des compositions pharmaceutiques ainsi obtenus. Expired - Fee Related FR2932682B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0803499A FR2932682B1 (fr) 2008-06-23 2008-06-23 Nouvelles formes pharmaceutiques a effet rapide et les utilisations des compositions pharmaceutiques ainsi obtenus.
EP09784216A EP2323627A1 (fr) 2008-06-23 2009-06-23 Nouvelles formes pharmaceutiques à effet rapide et les utilisations de composition pharmaceutiques ainsi obtenues
PCT/FR2009/000752 WO2010007232A1 (fr) 2008-06-23 2009-06-23 Nouvelles formes pharmaceutiques à effet rapide et les utilisations de composition pharmaceutiques ainsi obtenues

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0803499A FR2932682B1 (fr) 2008-06-23 2008-06-23 Nouvelles formes pharmaceutiques a effet rapide et les utilisations des compositions pharmaceutiques ainsi obtenus.

Publications (2)

Publication Number Publication Date
FR2932682A1 FR2932682A1 (fr) 2009-12-25
FR2932682B1 true FR2932682B1 (fr) 2013-07-12

Family

ID=40251785

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0803499A Expired - Fee Related FR2932682B1 (fr) 2008-06-23 2008-06-23 Nouvelles formes pharmaceutiques a effet rapide et les utilisations des compositions pharmaceutiques ainsi obtenus.

Country Status (3)

Country Link
EP (1) EP2323627A1 (fr)
FR (1) FR2932682B1 (fr)
WO (1) WO2010007232A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102016002120A1 (de) 2016-02-24 2017-08-24 Giesecke & Devrient Gmbh Sicherheitsmerkmal und Verfahren zu dessen Herstellung
DE102016006931A1 (de) 2016-06-06 2017-12-07 Giesecke+Devrient Currency Technology Gmbh Sicherheitsmerkmal und Verfahren zu dessen Herstellung
DE102017000124A1 (de) 2017-01-09 2018-07-12 Giesecke+Devrient Currency Technology Gmbh Sicherheitselement mit gelaserter Oberfläche

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2722984B1 (fr) 1994-07-26 1996-10-18 Effik Lab Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
GT199900061A (es) * 1998-05-15 2000-10-14 Pfizer Formulaciones farmaceuticas.
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
BR0210867A (pt) * 2001-07-06 2004-06-29 Lifecycle Pharma As Processo para a preparação de um material particulado, métodos para aglomeração controlada de um material sólido finamente disperso, para melhorar a biodisponibilidade de uma substância terapêutica e/ou profilaticamente ativa, e para melhorar a vida em prateleira de uma composição farmacêutica, material articulado, composição farmacêutica, uso de um veìculo, material particulado farmacêutico, e, uso de aluminossilicato de magnésio e/ou de aluminometassilicato de magnésio
EP1680091B1 (fr) * 2003-10-10 2017-05-31 Veloxis Pharmaceuticals A/S Forme de dose solide comprenant un fibrate
WO2007087452A2 (fr) * 2006-01-27 2007-08-02 Theraquest Biosciences, Llc Formulations à libération prolongée empêchant l'usage abusif et méthodes d'utilisation de celles-ci

Also Published As

Publication number Publication date
EP2323627A1 (fr) 2011-05-25
WO2010007232A1 (fr) 2010-01-21
WO2010007232A4 (fr) 2010-04-29
WO2010007232A9 (fr) 2010-03-11
FR2932682A1 (fr) 2009-12-25

Similar Documents

Publication Publication Date Title
LTPA2018014I1 (lt) Farmacinė kompozicija 514
BRPI0906962A2 (pt) Composto, e, composição farmacêutica
BRPI0906556A2 (pt) Composto, e, composição farmacêutica
BRPI0905369A2 (pt) Composição farmacêutica, composição e kit compartimentado
BRPI0913447A2 (pt) composição de éster, e, composição para cuidado pessoal.
BRPI0923836A2 (pt) Composições farmacêuticas orais contendo opióide e métodos
BRPI0917110A2 (pt) composição aquosa para o cuidado pessoal, cuidado doméstico, ou para o cuidado de tecidos, e, métodos para a modificação reológica de uma composição para o cuidado pessoal, o cuidado doméstico ou o cuidado dos tecidos
BRPI0916605A2 (pt) novos copolimeros e composições lubrificantes destes
BRPI0908021A2 (pt) Composto, composição farmacêutica, e, usos do composto ou da composição farmacêutica
BRPI0918652A2 (pt) Composições farmacêuticas e métodos de libração relacionadas.
DK2107905T3 (da) Fast sammensætning omfattende alogliptin og pioglitazon
BRPI0922531A2 (pt) composições de cuidado doméstico e pessoal
BRPI0921822A2 (pt) composição compreendendo polímero e enzima
BRPI0906980A2 (pt) Composição de derivados e maleatados
BRPI0917681A2 (pt) Composto, e, composição farmacêutica
BRPI0924137A2 (pt) composição farmacêutica sólida compreendendo amlodipina e losartan com melhor estabilidade
BRPI1015064A2 (pt) composições para tratar vício de droga e comportamento relacionado ao vício
BRPI0822337A2 (pt) Folatos, composições e usos dos mesmos
NL1036050C (nl) Brandvertragende en brandwerende samenstelling.
CL2010001422A1 (es) Uso de dronedarona para la preparacion de un medicamento util en la prevencion de la fibrilacion/aleteo auricular permanente
BRPI0905715A2 (pt) Composição farmacêutica e kit de componentes
BRPI0918206A2 (pt) derivados de animoéster e composição medicinal destes
DK2254873T3 (da) Benzodiazepinforbindelse og farmaceutisk sammensætning.
DK2125019T3 (da) Forbedrede medicinsammensætninger omfattende buprenorfin og naltrexon
BRPI0807905A2 (pt) Composições medicinais aperfeiçoadas compreendendo buprenorfina e naloxona.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

ST Notification of lapse

Effective date: 20170228